Charles S. Ryan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Quince Therapeutics, Inc., BioRestorative Therapies, Inc., APPLIED DNA SCIENCES INC, Neurotrope, Inc., and Polaryx Therapeutics, Inc..

2019 was Charles S. Ryan's most active year for acquiring shares with 8 total transactions. Charles S. Ryan's most active month to acquire stocks was the month of February. 2019 was Charles S. Ryan's most active year for disposing of shares, totalling 5 transactions. Charles S. Ryan's most active month to dispose stocks was the month of February. 2017 saw Charles S. Ryan paying a total of $105,001.80 for 360,457 shares, this is the most they've acquired in one year. In 2020 Charles S. Ryan cashed out on 557,695 shares for a total of $0.00, their largest year based on trade value.